December 2007, Volume 37 Number 12, p 30 - 30
Join NursingCenter to get uninterrupted access to this article and our entire library of paid articles and eBooks.
December 2007, Volume 37 Number 12 , p 30 - 30
Citing a lack of consumer acceptance, Pfizer, Inc., has announced that it will no longer market Exubera, its inhaled insulin product. In the announcement, the company said the product has been safe and effective, but too few patients and practitioners are using it to warrant further investment. Patients using Exubera are advised to work with their practitioners to make the transition to other insulin products. For more information, visit http://www.exubera.com.
Join NursingCenter on Social Media to find out the latest news and special offers
Connect with us on Facebook, Twitter, Linkedin and Google+
Copyright © 2015, Wolters Kluwer – Terms & Privacy – Disclaimer